Table 2.
Recent studies evaluating prevalence and outcomes of depression in CKD
First author, year, ref | Sample characteristics | Measurement tool for depression | Depression prevalence | Follow-up | Outcomes of depression |
---|---|---|---|---|---|
Hedayati, 201022 | 267 Patients with stage 2–5 CKD | DSM-IV interview (MDE diagnosis) |
21% | 1 yr |
|
Fischer, 20117 | 628 Patients with stage 2–4 CKD | BDI-II score > 14 or ≥11 | 26 or 42% | 5 yr |
|
Kop, 201119 | 5785 Patients, average GFR 78 | CES-D ≥ 8 | 21.2% | 14 yr |
|
Cukor, 20124 | 70 Patients with stage 1–4 CKD | BDI-II score ≥14 | 30% | 6 mo |
|
Fischer, 201220 | 3853 Patients with stage 2–4 CKD | BDI-II score ≥ 11 | 27.4% | None | |
Tsai, 20126 | 428 Patients with stage 3–5 CKD | BDI-II score ≥ 11 | 37% | 4 yr |
|
Lee, 20135 | 208 Patients with stage 3–5 CKD | HADS-D ≥ 8 | 47.1% | None |
|
Chiang, 201523 | 262 Patients (60.3% stage 4 and above) | Taiwanese Depression Questionnaire | 21% | 3 yr |
|
AKI, acute kidney injury; BDI, Beck Depression Inventory; CESD, Center for Epidemiologic Studies Depression Scale; CKD, chronic kidney disease; DSM IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edition; ESRD, end-stage renal disease; GFR, glomerular filtration rate; HADS-D, Hospital Anxiety and Depression Scale−depression subscale; HR, hazard ratio; MDE, major depressive episode; QOL, quality of life; ref, reference.